GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HAEMATO AG (STU:HAEK) » Definitions » Market Cap

HAEMATO AG (STU:HAEK) Market Cap : €109.8 Mil (As of Jun. 24, 2024)


View and export this data going back to . Start your Free Trial

What is HAEMATO AG Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). HAEMATO AG's share price for the quarter that ended in Jun. 2023 was €22.8. HAEMATO AG's Shares Outstanding (EOP) for the quarter that ended in Jun. 2023 was 5.2 Mil. Therefore, HAEMATO AG's market cap for the quarter that ended in Jun. 2023 was €119.2 Mil.

HAEMATO AG's quarterly market cap declined from Jun. 2022 (€110.9 Mil) to Dec. 2022 (€84.7 Mil) but then increased from Dec. 2022 (€84.7 Mil) to Jun. 2023 (€119.2 Mil).

HAEMATO AG's annual market cap increased from Dec. 2020 (€106.4 Mil) to Dec. 2021 (€125.0 Mil) but then declined from Dec. 2021 (€125.0 Mil) to Dec. 2022 (€84.7 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. HAEMATO AG's Enterprise Value for Today is €86.5 Mil.


HAEMATO AG Market Cap Historical Data

The historical data trend for HAEMATO AG's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HAEMATO AG Market Cap Chart

HAEMATO AG Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 106.94 67.18 106.45 124.98 84.71

HAEMATO AG Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 144.33 124.98 110.86 84.71 119.23

Competitive Comparison of HAEMATO AG's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, HAEMATO AG's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HAEMATO AG's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, HAEMATO AG's Market Cap distribution charts can be found below:

* The bar in red indicates where HAEMATO AG's Market Cap falls into.



HAEMATO AG Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

HAEMATO AG's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as

Market Cap (A: Dec. 2022 )=Share Price (A: Dec. 2022 )*Shares Outstanding (EOP) (A: Dec. 2022 )
=€16.2*5.22931
=€84.7

HAEMATO AG's Market Cap for the quarter that ended in Jun. 2023 is calculated as

Market Cap (Q: Jun. 2023 )=Share Price (Q: Jun. 2023 )*Shares Outstanding (EOP) (Q: Jun. 2023 )
=€22.8*5.22931
=€119.2

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HAEMATO AG  (STU:HAEK) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


HAEMATO AG Market Cap Related Terms

Thank you for viewing the detailed overview of HAEMATO AG's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


HAEMATO AG (STU:HAEK) Business Description

Traded in Other Exchanges
Address
Lilienthalstrasse 5c, Schonefeld, DEU, D-12529
HAEMATO AG is a Germany based pharmaceutical company. It provides pharmaceuticals for the care of chronically ill people. The firm is engaged in the sale of generic and EU (European countries) import drugs. It is focused on patented and non-patented medicinal products. The company product portfolio includes human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), neurology, oncology, rheumatology, and urology. Geographically, it operates only in Germany.

HAEMATO AG (STU:HAEK) Headlines

No Headlines